Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2015 Annual Report

2016 Proxy Statement

2016 Proxy Statement (Supplement)

2014 Annual Report

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement


Recent Releases

May 3, 2016
GenMark Reports First Quarter 2016 Results

Apr 19, 2016
GenMark Diagnostics Schedules First Quarter 2016 Financial Results Conference Call for May 3, 2016

View all releases »

Events

May 3, 2016 at 4:30 PM ET
GenMark Diagnostics First Quarter Earnings Conference Call

View all events »

Related Links

Stock Quote
Price:
7.32
Change:
+ 0.17
Day High:
7.32
Day Low:
7.05
Volume:
167,571
NASDAQ
GNMK
4:00 PM ET on May 27, 2016
Delayed at least 20 minutes.
Provided by eSignal.